Ovarian Granulosa Cell Tumor — Trials

Ovarian Granulosa Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05348356	Nirogacestat in Ovarian Granulosa Cell Tumors	completed	Phase 2	53	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	3	Aug 25, 2026	clinicaltrials
NCT06254781	Luspatercept in Metastatic AGCT of the Ovary	completed	N/A	1	University Health Network, TorontoOTHER	1	Feb 12, 2024	clinicaltrials
NCT00006227	Paclitaxel in Treating Patients With Ovarian Stromal Cancer	completed	Phase 2	31	Gynecologic Oncology GroupNETWORK	2	Mar 5, 2020	clinicaltrials
NCT00748657	Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials